In vivo anti-tumor structure-activity relationships of Judemycin C and E, small molecule modulators of the spliceosome

被引：0
|
作者：
Webb, T. R. [1 ]
Lagisetti, C. [1 ]
Pourpak, A. [1 ]
Morris, S. W. [1 ]
Potter, P. M. [1 ]
机构：
[1] St Jude Childrens Hosp, Memphis, TN 38105 USA
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(10)71802-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [31] Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: Structure-activity relationships and selective binding patterns
    Moore, Susanna
    Jaeschke, Holger
    Kleinau, Gunnar
    Neumann, Susanne
    Costanzi, Stefano
    Jiang, Jian-kang
    Childress, John
    Raaka, Bruce M.
    Colson, Anny
    Paschke, Ralf
    Krause, Gerd
    Thomas, Craig J.
    Gershengorn, Marvin C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (13) : 3888 - 3896
  • [32] A Comprehensive Overview of Structure-Activity Relationships of Small-Molecule Splicing Modulators Targeting SF3B1 as Anticancer Agents
    Zhang, Datong
    Meng, Fancui
    CHEMMEDCHEM, 2020, 15 (22) : 2098 - 2120
  • [33] Tumor specific cytotoxicity of β-glucosylceramide: structure-cytotoxicity relationship and anti-tumor activity in vivo
    Oku, Hirosuke
    Li, Changchun
    Shimatani, Masayuki
    Iwasaki, Hironori
    Toda, Takayoshi
    Okabe, Takafumi
    Watanabe, Hisami
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (03) : 485 - 496
  • [34] Anti-tumor activity of de novo designed small globular protein (SGP) in vivo
    Tsugu, Hitoshi
    Onishi, Hirokazu
    Fukushima, Takeo
    Lee, Sannamu
    ANTICANCER RESEARCH, 2006, 26 (6A) : 4043 - 4046
  • [35] Anti-tumor effects of a small molecule C-C chemokine receptor 4 inhibitor in mouse tumor models
    Li, C.
    Campbell, J. J.
    Ertl, L. S.
    Miao, Z.
    Chhina, V.
    Kumamoto, A.
    Yau, S.
    Dang, T.
    Zhang, P.
    Schall, T. J.
    Singh, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [36] Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1
    Bach, Anders
    Stuhr-Hansen, Nicolai
    Thorsen, Thor S.
    Bork, Nicolai
    Moreira, Irina S.
    Frydenvang, Karla
    Padrah, Shahrokh
    Christensen, S. Brogger
    Madsen, Kenneth L.
    Weinstein, Harel
    Gether, Ulrik
    Stromgaard, Kristian
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2010, 8 (19) : 4281 - 4288
  • [37] Small-molecule glucosylation by sucrose phosphmylase: structure-activity relationships for acceptor substrates revisited
    Luley-Goedl, Christiane
    Nidetzky, Bernd
    CARBOHYDRATE RESEARCH, 2010, 345 (10) : 1492 - 1496
  • [38] Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonists
    Throup, Adam
    Zraikat, Manar Saleh
    Gordon, Andrew
    Jafarinejad Soumehsaraei, Shohreh
    Haase, Kathrin D.
    Patterson, Laurence H.
    Cooper, Patricia A.
    Hanlon, Katherine
    Loadman, Paul M.
    Sutherland, Mark
    Shnyder, Steven D.
    Sheldrake, Helen M.
    RSC MEDICINAL CHEMISTRY, 2024,
  • [39] Investigation of Structure-Activity Relationships for Small-Molecule Inhibitors of Human DNA Polymerase Eta
    Zafar, Maroof K.
    Maddukuri, Leena
    Eddy, Sarah
    Ketkar, Amit
    Penthala, Narsima R.
    Crooks, Peter A.
    Eoff, Robert L.
    FASEB JOURNAL, 2016, 30
  • [40] Novel small molecule inhibitors of p97 demonstrate anti-tumor effects in vitro and in vivo
    Anderson, D.
    Djakovic, S.
    Kissvonsoly, S.
    Le Moigne, R.
    Rice, J.
    Rolfe, M.
    Soriano, F.
    Valle, E.
    Wang, J.
    Wong, S.
    Wustrow, D.
    Yakes, M.
    Yao, B.
    Zhou, H-J.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
12345